SCIENTIFIC PROGRAMME
SESSION I
THE GENOMIC AND
EPIGENOMIC LANDSCAPE
OF CLL AND CLINICAL
CONSEQUENCES
SESSION II
THE ROLE OF BCR
ACTIVATION AND
SIGNALLING FOR CLL
SESSION III
THERAPEUTIC OPTIONS
FOR CLL
SESSION IV
LONG TERM FOLLOW
UP OF CLINICAL TRIALS
VERSUS REAL WORLD
DATA (OUTSIDE CLINICAL
TRIALS DATA-OCT)
SESSION V
THE INCREASING ROLE
OF THE LEUKAEMIC
MICROENVIRONMENT
SESSION VI
THERAPEUTIC OPTIONS 2 :
THE USE OF CELLULAR
AND NON-CELLULAR
IMMUNOTHERAPIES IN
CLL
SESSION VII
EFFICACY THROUGH
SAFETY
SESSION VIII
CLONAL HETEROGENEITY,
CLONAL EVOLUTION AND
MECHANISMS OF DRUG
RESISTANCE
SESSION IX
CONTRASTING
THERAPEUTIC CONCEPTS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
FACULTY DISCLOSURES
C. Moreno Not received
J. Moslehi Novartis
Pfizer
Bristol-Myers Squibb
Takeda/Millennium
Ariad
Acceleron
Vertex
Incyte
Rgenix
Verastem
Pharmacyclics
StemCentRx
Heat Biologics
Daiichi Sakyo
Regeneron
Myokardia
Ipsen
Deciphera
Refux Therapeutics
AstraZeneca
Nektar
Audentes Therapeutics
Intrexon
U.S Federal and Drug
Administration (FDA)
Consultant
Consultant / Research Grants
Consultant / Research Grants
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant
Consultant / Equity
Consultant
Consultant
Consultant
Consultant
Consultant (not paid)
C. Oakes No dislosure
P. Oppezzo Abbvie Research support
C. Pighi No dislosure
A. Rawstron AbbVie
BD Sciences
Beckman Coulter
Celgene
Gilead
Janssen
Pharmacyclics
Roche
Research support / Speakers’ bureau / Scientific
Advisory Board / Royalties
Research support
Research support / Speakers’ bureau
Research support / Consultant / Scientific Advisory
Board
Research support / Consultant / Scientific Advisory
Board
Research support / Scientific Advisory Board
Research support / Consultant
Research support / Scientific Advisory Board
L. Roeker Abbvie
Abbott Laboratories
Pharmacyclics
Vaniam Group
Minority stockholder
Minority stockholder
Consultant
Consultant
D. Rossi Abbvie
AstraZeneca
Janssen
Gilead
Verastem
Loxo
Roche
Research support / Scientific Advisory Board
Research support / Scientific Advisory Board
Research support / Scientific Advisory Board
Research support / Scientific Advisory Board
Scientific Advisory Board
Scientific Advisory Board
Scientific Advisory Board